United States · Biotechnology startup
United States · Maze Therapeutics
Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
Funding reportedLast round: Undisclosed round
What company datasets say Maze Therapeutics raised
Funding, as reported
Reported in all$381Min dollars
Rounds3
Last roundUndisclosed round
Last round dateJan 2022
Investors listed15
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Maze Therapeutics in front of investors. Or tell us what we have wrong.